Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $35000.0 on Dec 22 ’23. In the deal valued at $1.40 per share,25,000 shares were bought. As a result of this transaction, Dunne Michael W. now holds 113,754 shares worth roughly $0.18 million.
Then, Dunne Michael W. bought 10,000 shares, generating $18,442 in total proceeds. Upon buying the shares at $1.84, the Director now owns 88,754 shares.
Before that, Dunne Michael W. bought 20,000 shares. Iterum Therapeutics Plc shares valued at $40,690 were divested by the Director at a price of $2.03 per share. As a result of the transaction, Dunne Michael W. now holds 78,754 shares, worth roughly $0.12 million.
Gabelli & Co upgraded its Iterum Therapeutics Plc [ITRM] rating to a Hold from a a Sell in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in mid March from “a Neutral” to “a Buy”. RBC Capital Mkts also remained covering ITRM and has decreased its forecast on June 02, 2020 with a “Sector perform” recommendation from previously “an Outperform” rating. Gabelli & Co revised its rating on January 21, 2020. It rated ITRM as “a Sell” which previously was an “a Buy”.
Price Performance Review of ITRM
On Monday, Iterum Therapeutics Plc [NASDAQ:ITRM] saw its stock fall -7.78% to $1.54. Over the last five days, the stock has lost -2.53%. Iterum Therapeutics Plc shares have fallen nearly -21.83% since the year began. Nevertheless, the stocks have risen 44.60% over the past one year. While a 52-week high of $2.50 was reached on 01/30/24, a 52-week low of $0.62 was recorded on 02/23/24. SMA at 50 days reached $1.5193, while 200 days put it at $1.3069. A total of 0.51 million shares were traded, compared to the trading of 36000.0 shares in the previous session.
Levels Of Support And Resistance For ITRM Stock
The 24-hour chart illustrates a support level at 1.4300, which if violated will result in even more drops to 1.3200. On the upside, there is a resistance level at 1.7000. A further resistance level may holdings at 1.8600. The Relative Strength Index (RSI) on the 14-day chart is 48.31, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0440, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 63.64%. Stochastics %K at 49.34% indicates the stock is a holding.
